GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lisata Therapeutics Inc (NAS:LSTA) » Definitions » E10

Lisata Therapeutics (Lisata Therapeutics) E10 : $-80.83 (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Lisata Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lisata Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.660. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-80.83 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 32.20% per year. During the past 5 years, the average E10 Growth Rate was 34.00% per year. During the past 10 years, the average E10 Growth Rate was 33.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Lisata Therapeutics was 39.40% per year. The lowest was 17.00% per year. And the median was 29.40% per year.

As of today (2024-04-27), Lisata Therapeutics's current stock price is $2.6478. Lisata Therapeutics's E10 for the quarter that ended in Dec. 2023 was $-80.83. Lisata Therapeutics's Shiller PE Ratio of today is .


Lisata Therapeutics E10 Historical Data

The historical data trend for Lisata Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lisata Therapeutics E10 Chart

Lisata Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -336.63 -259.64 -178.46 -114.40 -80.83

Lisata Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -114.40 -106.11 -98.30 -90.35 -80.83

Competitive Comparison of Lisata Therapeutics's E10

For the Biotechnology subindustry, Lisata Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lisata Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lisata Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lisata Therapeutics's Shiller PE Ratio falls into.



Lisata Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lisata Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.66/129.4194*129.4194
=-0.660

Current CPI (Dec. 2023) = 129.4194.

Lisata Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201403 -73.500 99.695 -95.415
201406 -60.000 100.560 -77.220
201409 -72.000 100.428 -92.785
201412 -46.500 99.070 -60.745
201503 -76.500 99.621 -99.382
201506 -57.600 100.684 -74.039
201509 -30.900 100.392 -39.835
201512 -94.050 99.792 -121.972
201603 -31.350 100.470 -40.383
201606 -19.950 101.688 -25.391
201609 -16.350 101.861 -20.773
201612 -8.100 101.863 -10.291
201703 -16.800 102.862 -21.137
201706 65.100 103.349 81.522
201709 -5.700 104.136 -7.084
201712 -5.700 104.011 -7.092
201803 -7.800 105.290 -9.588
201806 -6.300 106.317 -7.669
201809 -5.400 106.507 -6.562
201812 -5.400 105.998 -6.593
201903 -6.600 107.251 -7.964
201906 -7.350 108.070 -8.802
201909 -7.050 108.329 -8.423
201912 -7.200 108.420 -8.595
202003 -5.700 108.902 -6.774
202006 7.500 108.767 8.924
202009 -4.350 109.815 -5.127
202012 -5.100 109.897 -6.006
202103 -2.850 111.754 -3.300
202106 -1.500 114.631 -1.694
202109 -1.740 115.734 -1.946
202112 -1.690 117.630 -1.859
202203 -1.050 121.301 -1.120
202206 -1.640 125.017 -1.698
202209 -7.880 125.227 -8.144
202212 -0.758 125.222 -0.783
202303 -0.770 127.348 -0.783
202306 -0.500 128.729 -0.503
202309 -0.650 129.860 -0.648
202312 -0.660 129.419 -0.660

Add all the adjusted EPS together and divide 10 will get our e10.


Lisata Therapeutics  (NAS:LSTA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lisata Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Lisata Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Lisata Therapeutics (Lisata Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.
Executives
David W. Slack director, officer: President & CBO 110 ALLEN ROAD, 2ND FLOOR, BASKING RIDGE NJ 07920
Heidi Henson director 2173 SALK AVENUE, SUITE 250, PMB#052, CARLSBAD CA 92008
Mohammad Azab director C/O SUPERGEN, INC., 4140 DUBLIN BLVD., SUITE 200, DUBLIN CA 94568
Erkki Ruoslahti director P.O. BOX 544, BUELLTON CA 93427
Steven S Myers director 4695 MACAUTHUR COURT, EIGHTH FLOOR, NEWPORT BEACH CA 92660
Kristen K Buck officer: EVP, R&D and CMO 110 ALLEN ROAD, 2ND FLOOR, BASKING RIDGE NJ 07920
Todd C Girolamo officer: CLO, SVP of Corp Dev 110 ALLEN ROAD, 2ND FLOOR, BASKING RIDGE NJ 07920
Anne Clem Whitaker director 109 BRIERY BRANCH COURT, MORRISVILLE NC 27560
Michael H. Davidson director OMTHERA PHARMACEUTICALS, INC., 707 STATE ROAD, PRINCETON NJ 08540
Cynthia Schwalm director C/O G1 THERAPEUTICS, 700 PARK OFFICES DR, SUITE 200, P.O. BOX 110341, RESEARCH TRIANGLE PARK NC 27709
David J Mazzo director, officer: Chief Executive Officer 110 ALLEN ROAD, 2ND FLOOR, BASKING RIDGE NJ 07920
Joseph Talamo officer: SVP and CFO CALADRIUS BIOSCIENCES, INC., 800 WESTCHESTER AVENUE. STE N341, RYE BROOK NY 10573
Douglas W Losordo officer: See Remarks 13 FOX MEADOW RD, SCARSDALE NY 10583
Anford 10 percent owner P.O. BOX 5039, SIOUX FALLS SD 57117
Health Sanford 10 percent owner P.O. BOX 5039, SIOUX FALLS SD 57117